home genetic news bioinformatics biotechnology literature journals ethics positions events sitemap


UBBFriend: Email This Page to Someone!
  HUM-MOLGEN
  Biotechnical requests and sources
  Otava release set of 80 new protein kinase focused libraries

Post New Topic  Post A Reply
profile | register | preferences | faq | search

next newest topic | next oldest topic
Author Topic:   Otava release set of 80 new protein kinase focused libraries
grischenko
Member
posted 09-03-2009 11:47 AM     Click Here to See the Profile for grischenko   Click Here to Email grischenko     Edit/Delete Message Reply w/Quote
Kyiv, Ukraine, 5th of December, 2009 – OTAVA Ltd., a chemical and drug discovery company which is focused on developing kinase inhibitors, in silico & molecular modeling for pharmaceutical research as well as combinatorial chemistry and development of fluorescent probes is pleased to release its new product – a set of 80 new protein kinase focused libraries.
“This is a new product we are distributing on the market since January, 2009” – said Victor Matyushok, CEO of OTAVA. “It is based on our many years of experience in this field. To prepare these focused libraries, our experts have implemented a number of crucial improvements of a calculation algorithm which include calculation of atom charges as well as unique force field and scoring functions. Our goal is to cover all possible protein kinase targets for which crystal structures are resolved. It gives an unprecedented choice of focused libraries to our customers” – he stated.
A core of the focused library preparation algorithm is flexible receptor-ligand docking. Each library is based on OTAVA’s in-house collection of about 500,000 compounds.
OTAVA offers competitive prices and flexible discounts.

About OTAVA
OTAVA supplies fine organic chemicals including unique building blocks for combinatorial synthesis. The company provides compound libraries for screening and it offers custom synthesis and molecular modeling services, targeted compound libraries and protein kinase inhibitors, prescreened anticancer compounds, peptide and chromogenic substrates. OTAVA is also one of the leaders in design and development of fluorescent probes, kits and reagents.

Contact us:

OTAVA Ltd.
150 Zabolotnogo St.
Kyiv, 03143, Ukraine
Tel./Fax: +380 44 522 2458
mol.design@otavachemicals.com www.otavachemicals.com
------------------------------------------------------
OTAVA – North American Division
55 Ellerslie Ave., Suite 524
Toronto, Ontario, M2N 1X9
Canada
Tel.: 1-416-305-9979
Fax: 1-866-881-9921
(Toll-free in US & Canada)
north.america@otavachemicals.com

IP: 217.27.154.230

All times are ET (US)

next newest topic | next oldest topic

Administrative Options: Close Topic | Archive/Move | Delete Topic
Post New Topic  Post A Reply
Hop to:

Contact Us | HUM-MOLGEN

Copyright by HUM-MOLGEN 1995-2017

Powered by: Ultimate Bulletin Board, Version 5.44a
© Infopop Corporation (formerly Madrona Park, Inc.), 1998 - 2000.